Download by
Scanning QR Code
No Stock Yet
No Data
CP Enterprise International (03839.HK) plans to acquire a majority interest in Chinese veterinary drugs.
03839.HK announced that on May 11, 2022, the company's non-wholly owned subsidiary, Pucheng CP, signed a framework agreement with the target company and its controlling shareholders on the possible subscription and purchase of majority interests in the target company. The target company is established in accordance with Chinese law, mainly engaged in the development and production of veterinary drugs. Possible transactions are subject to, among other things, the satisfaction of Pucheng CP University with the due diligence results of the target company and the signing of the final agreement.
CP International (03839) plans to purchase most of the rights and interests of a veterinary drug company engaged in development and production.
Zhitong Financial APP News, CP International (03839) issued an announcement that on May 11, 2022, Pucheng CP, a non-wholly owned subsidiary of the company, signed a framework agreement with the target company and the controlling shareholders of the target company on the possible subscription and purchase of most of the rights and interests of the target company. The target company is established in accordance with Chinese law, mainly engaged in the development and production of veterinary drugs. Possible transactions are subject to, among other things, the satisfaction of Pucheng CP University with the due diligence results of the target company and the signing of the final agreement.
CP International (03839.HK) changed from profit to loss of 1.83 million US dollars in the first quarter.
On May 11, 03839.HK announced that for the three months ended March 31, 2022, the company's income was US $39.12 million, an increase of 9.4% over the same period last year. It lost US $1.83 million during the period and made a profit of US $5.86 million in the same period last year.
CP International (03839) released first-quarter results, resulting in a loss of $2.088 million attributable to shareholders.
Zhitong Financial APP News, CP International (03839) released its results for the three months ended March 31, 2022, with revenue of US $39.123 million, an increase of 9.4% over the same period last year, and a loss of US $2.088 million attributable to the company's shareholders, compared with a profit of US $5.254 million in the same period last year.
CP International: unaudited results for the three months ended March 31, 2022
03839.HK Board of Directors approves first quarter results on May 11th
03839.HK announced that it will hold a board meeting on Wednesday, May 11, 2022 to, among other things, approve the unaudited results of the company and its subsidiaries for the three months ended March 31, 2022.
CP International: the date of the board of directors
CP International: annual report 2021
CP International (03839.HK) expects profit and loss to turn to US $2 million in the first quarter.
On April 20, 03839.HK announced that the Group expects to record an unaudited consolidated loss of approximately US $2 million for the three months ended March 31, 2022, compared with a profit of US $5.3 million for the same period last year. The change from profit to loss is mainly due to the unsatisfactory performance of the group's industrial business. The profit attributable to the joint venture (Yi Chu Mingtong Investment Co., Ltd.) is expected to deteriorate from a profit of $4.4 million in the first quarter of 2021 to a loss of about $3 million in the first quarter of 2022.
CP International (03839) issued a profit warning and expected shareholders to account for a comprehensive loss of US $2 million in the first quarter compared with the same period last year.
Zhitong Financial APP News, CP International (03839) announced that the Group expects to make a consolidated loss of about $2 million attributable to unaudited shareholders in the first quarter of 2022, compared with a profit of $5.3 million in the first quarter of 2021. The change from profit to loss is mainly due to the unsatisfactory performance of the group's industrial business, the announcement said. The profit attributable to the joint venture (Yi Chu Mingtong Investment Co., Ltd.) is expected to deteriorate from a profit of $4.4 million in the first quarter of 2021 to a loss of about $3 million in the first quarter of 2022.
Loading...
No Stock Yet